J1002901JASON DANDRUFF RELIEF 2IN1TREATMENT (ZINC PYRITHIONE) SHAMPOO [THE HAIN CELESTIAL GROUP, INC.]

J1002901JASON DANDRUFF RELIEF 2IN1TREATMENT (ZINC PYRITHIONE) SHAMPOO [THE HAIN CELESTIAL GROUP, INC.]
PDF | XML

NDC 61995-0129-8
Set ID 624c1961-57e2-79e5-e053-2991aa0aec27
Category HUMAN OTC DRUG LABEL
Packager The Hain Celestial Group, Inc.
Generic Name
Product Class
Product Number
Application Number PART358H
  • ACTIVE INGREDIENT

    Zinc Pyrithiopne 1.0%

    Close
  • PURPOSE

    Controls Dandruff

    Close
  • INDICATIONS & USAGE

    • Controls recurrence of flaking, scaling and itching associated with dandruff
    • Helps prevent seborrheic dermatitis
    Close
  • WARNINGS

    For external use only . Avoid contact with eyes.Rinse eyes throughly with water in case contact occurs.Discontinue use and consult your physician if irritation develops.

    Close
  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed get medical help or contact Poison Center right away.

    Close
  • DOSAGE & ADMINISTRATION

    For best results use at least three times each week. Wet hair and lather, massage into scalp. Rinse and repeat if desired.


    Close
  • INACTIVE INGREDIENT

    Aqua (Water), Cetyl Alcohol, Glycerin, Sodium Cocoyl Isothionate, Cocamidopropyl Hydroxysultaine, Stearyl Alcohol,Glyceryl Stearate SE, Disodium Cocoyl Glutamate, Sodium Chloride, Caprylic/Capric Trigluceride, Olea Europaea (Olive) Fruit Oil (1), Simmondsia Chinensis (Jojoba) Seed Oil (1), Citrus Aurantium Dulcis (Orange) Peel Oil, Babassu Oil Polyglyceryl-4 Esters, Alcohol (1), Chenopodium Quinoa Seed (1), Benzyl Acetate, Capryloyl Glycerin/Sebacid Acid Copolymer, Cyamopsis Tetragonoloba (Guar) Gum, Sodium Hydroxide, Sodium PCA, Terpineol, Zinc Carbonate, Diheptyl Succinate,Guar Hydroxypropyltrimonium Chloride,Terpineol,Triethyl Citrate, Ethylhexylglycerin, Phenoxyethanol.

    (1)

    Certified Organic Ingredients


    Close
  • INGREDIENTS AND APPEARANCE
    J1002901JASON DANDRUFF RELIEF 2IN1TREATMENT 
    zinc pyrithione shampoo
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:61995-0129
    Route of Administration TOPICAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC 1 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM COCOYL ISETHIONATE (UNII: 518XTE8493)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    BABASSU OIL (UNII: 8QSB4M5477)  
    OLIVE OIL (UNII: 6UYK2W1W1E)  
    JOJOBA OIL (UNII: 724GKU717M)  
    ZINC CARBONATE (UNII: EQR32Y7H0M)  
    GUAR GUM (UNII: E89I1637KE)  
    DIHEPTYL SUCCINATE (UNII: 057N7SS26Y)  
    SODIUM PYRROLIDONE CARBOXYLATE (UNII: 469OTG57A2)  
    COCAMIDOPROPYL HYDROXYSULTAINE (UNII: 62V75NI93W)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (1.7 SUBSTITUENTS PER SACCHARIDE) (UNII: B16G315W7A)  
    DISODIUM COCOYL GLUTAMATE (UNII: MBK0CP8F5A)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    ORANGE OIL (UNII: AKN3KSD11B)  
    GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
    CHENOPODIUM QUINOA SEED (UNII: OO4K72NZ2X)  
    ALCOHOL (UNII: 3K9958V90M)  
    BENZYL ACETATE (UNII: 0ECG3V79ZJ)  
    CAPRYLOYL GLYCERIN/SEBACIC ACID COPOLYMER (2000 MPA.S) (UNII: N7YC58165T)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:61995-0129-8 355 g in 1 BOTTLE; Type 0: Not a Combination Product 11/27/2017
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC monograph final part358H 11/27/2017
    Labeler - The Hain Celestial Group, Inc. (858894996)
    Registrant - The Hain Celestial Group, Inc. (858894996)
    Establishment
    Name Address ID/FEI Business Operations
    The Hain Celestial Group, Inc 014334364 manufacture(61995-0129)
    Close

Related Drugs